Patents by Inventor Eduardo J. Mascareno

Eduardo J. Mascareno has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diagnosis and treatment of prostate cancer
    Patent number: 9789159
    Abstract: The methods of the present disclosure are directed toward methods of diagnosis and treatment of cancer in a subject. The present disclosure provides methods of diagnosing abnormal cells in a subject by measuring the level of Hexim-1 in a sample from the subject, where elevated levels of Hexim-1 indicate abnormal cells. This disclosure further provides methods of treating cancer or hyperplasia, comprising administering to a subject in need thereof a therapeutically effective amount of Hexim-1 or an activator of Hexim-1 expression or activity.
    Type: Grant
    Filed: March 22, 2012
    Date of Patent: October 17, 2017
    Assignee: The Research Foundation for The State University of New York
    Inventors: Manya Dhar-Mascareno, Eduardo J. Mascareno
  • HEXIM-1 AS A TARGET OF LEPTIN SIGNALING TO REGULATE OBESITY AND DIABETES
    Publication number: 20150152421
    Abstract: Provided are Hexim-1 inhibitor compositions, and methods and kits using said compositions for the treating and regulating obesity and/or diabetes, comprising administering an effective amount of a Hexim-1 inhibitor. Additionally provided are methods for screening for inhibitors of Hexim-1.
    Type: Application
    Filed: June 14, 2013
    Publication date: June 4, 2015
    Applicant: MEDHEXIM, LLC
    Inventors: Eduardo J. Mascareno, Manya Dhar-Mascareno
  • DIAGNOSIS AND TREATMENT OF PROSTATE CANCER
    Publication number: 20140227172
    Abstract: The methods of the present disclosure are directed toward methods of diagnosis and treatment of cancer in a subject. The present disclosure provides methods of diagnosing abnormal cells in a subject by measuring the level of Hexim-1 in a sample from the subject, where elevated levels of Hexim-1 indicate abnormal cells. This disclosure further provides methods of treating cancer or hyperplasia, comprising administering to a subject in need thereof a therapeutically effective amount of Hexim-1 or an activator of Hexim-1 expression or activity.
    Type: Application
    Filed: March 22, 2012
    Publication date: August 14, 2014
    Applicant: THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
    Inventors: Manya Dhar-Mascareno, Eduardo J. Mascareno